[Ventricular proarrhythmia in the rhythm-control therapy for atrial fibrillation].
Nishimura
Hiroshi
H
Department of Pharmacoepidemiology, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000097:blood; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000503:physiopathology; D000075202:Contraindications; D016903:Drug Monitoring; D004359:Drug Therapy, Combination; D004562:Electrocardiography; D006339:Heart Rate; D006801:Humans; D017180:Tachycardia, Ventricular / Q000139:chemically induced* / Q000175:diagnosis / Q000517:prevention & control
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents